《b受体阻滞剂治疗心衰指南GuidelinesforthetreatmentofheartfailurewithBreceptorblockersin》由会员分享，可在线阅读，更多相关《b受体阻滞剂治疗心衰指南GuidelinesforthetreatmentofheartfailurewithBreceptorblockersin（21页珍藏版）》请在金锄头文库上搜索。
1、2007年b受体阻滞剂治疗心衰指南（Guidelines for the treatment of heart failure with B receptor blockers in 2007）The role of beta blockers in the treatment of chronic heart failure - an interpretation of the latest guidelines for the treatment of chronic heart failure in ChinaDaiguizhuUnion Hospital of Tongji Medic
2、al College of Huazhong University of Science and TechnologyIn recent years, both in basic research and clinical diagnosis and treatment, heart failure (HF) research has made remarkable progress, a large number of evidence-based medicine to change some of the traditional understanding of heart failur
3、e we, we need the corresponding change of diagnosis and treatment of heart failure. Therefore, our heart failure scholars refer to a large number of literature and research and foreign related guidelines, after repeated discussion and unremitting efforts, China on chronic heart failure treatment gui
4、delines were fully revised and updated, and will be in this month at the end of the grand launch. In the new guidelines, use of beta blockers in the treatment of chronic heart failure has been fully described, the treatment status has been further consolidated, Sinorama invited famous Chinese expert
5、 Professor Dai Guizhu on the part of heart failure in-depth interpretation.The latest edition of the guidelines for the treatment of chronic heart failure in China, once again referred to as a class I/ drug in the heart failure drug treatment, emphasizes its importance in the treatment of heart fail
6、ure:All chronic systolic heart failure, New York Heart Association (NYHA) II III, B, and stable stage of asymptomatic heart failure or NYHAI level in patients with left ventricular ejection fraction (LVEF) 3 months) after it can improve cardiac function and increase LVEF; for 4 12 months, can reduce
7、 ventricular muscle weight and structure capacity, improve the ventricular shape, suggesting that delaying or reversing myocardial remodeling. The acute and long-term treatment of different pharmacological effects are considered to improve the endogenous myocardial function biological effect, found
8、that the mechanism of the beta blockers into routine medication in treatment of chronic heart failure from contraindication. As Bristow MR said: in the past 10 years, the medical treatment of heart failure has a significant change: the treatment measures have been in the short term, the hemodynamic
9、/ pharmacology models to repair more long-term strategy is to effectively change the biological properties of heart failure. Therefore,Beta blockers have unique biological mechanisms for the treatment of heart failure and have opened up a new era for the treatment of heart failure.Two, evidence based medical evidence is adequate and benefits of heart failure therapy are considerableThe guide States, so far,More than 20 randomized controlled trials have been conducted wit
